Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The SCOPE-ITSCC Metastases Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01976468

Enrollment

100

Registered

2013-11-05

Start date

2013-11-30

Completion date

2025-01-31

Last updated

2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous Cell Carcinoma

Brief summary

The investigators hypothesize that a low number of SCC in OTR will metastasize.

Detailed description

In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.

Interventions

OTHERSCC metastasis

occurrence of SCC metastasis

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Organ-transplant recipients (OTR). * Histologically proven cutaneous invasive SCC at time of inclusion

Exclusion criteria

* Lack of consent. * History of metastases of cutaneous SCC

Design outcomes

Primary

Measure	Time frame
SCC metastasis detection	two years

Countries

Netherlands, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026